Freestone Grove Partners LP Takes Position in Maximus, Inc. (NYSE:MMS)

Freestone Grove Partners LP acquired a new position in shares of Maximus, Inc. (NYSE:MMS - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 23,008 shares of the health services provider's stock, valued at approximately $1,718,000.

Other hedge funds have also recently bought and sold shares of the company. UMB Bank n.a. boosted its stake in shares of Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after purchasing an additional 158 shares in the last quarter. Eastern Bank acquired a new position in shares of Maximus in the fourth quarter valued at approximately $29,000. V Square Quantitative Management LLC lifted its holdings in shares of Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after purchasing an additional 180 shares during the period. R Squared Ltd bought a new position in Maximus during the 4th quarter worth $54,000. Finally, IFP Advisors Inc raised its position in shares of Maximus by 62.4% during the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after acquiring an additional 302 shares during the last quarter. 97.21% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th.

Insider Activity at Maximus

In other news, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the sale, the insider now owns 2,512 shares of the company's stock, valued at approximately $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the transaction, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. The trade was a 11.88 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Maximus Stock Up 1.1 %

Shares of NYSE:MMS traded up $0.75 during trading on Wednesday, reaching $67.22. 493,027 shares of the stock were exchanged, compared to its average volume of 631,792. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97. The stock has a fifty day moving average of $67.64 and a two-hundred day moving average of $73.36. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The firm has a market cap of $3.80 billion, a price-to-earnings ratio of 14.46 and a beta of 0.61.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.79%. The ex-dividend date is Thursday, May 15th. Maximus's dividend payout ratio is currently 25.81%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.